Division of Psychiatry, Faculty of Brain Sciences, University College London, London, UK.
Mental Health Service, VA San Diego Healthcare System, San Diego, CA, USA.
Age Ageing. 2021 Sep 11;50(5):1751-1761. doi: 10.1093/ageing/afab059.
Generalised anxiety disorder (GAD) is the most common anxiety disorder in older people. First-line management includes pharmacological and psychological therapies, but many do not find these effective or acceptable. Little is known about how to manage treatment-resistant generalised anxiety disorder (TR-GAD) in older people.
To examine the acceptability, feasibility and preliminary estimates of the effectiveness of acceptance and commitment therapy (ACT) for older people with TR-GAD.
People aged ≥65 years with TR-GAD (defined as not responding to GAD treatment, tolerate it or refused treatment) recruited from primary and secondary care services and the community.
Participants received up to 16 one-to-one sessions of ACT, developed specifically for older people with TR-GAD, in addition to usual care.
Co-primary outcomes were feasibility (defined as recruitment of ≥32 participants and retention of ≥60% at follow-up) and acceptability (defined as participants attending ≥10 sessions and scoring ≥21/30 on the satisfaction with therapy subscale). Secondary outcomes included measures of anxiety, worry, depression and psychological flexibility (assessed at 0 and 20 weeks).
Thirty-seven participants were recruited, 30 (81%) were retained and 26 (70%) attended ≥10 sessions. A total of 18/30 (60%) participants scored ≥21/30 on the satisfaction with therapy subscale. There was preliminary evidence suggesting that ACT may improve anxiety, depression and psychological flexibility.
There was evidence of good feasibility and acceptability, although satisfaction with therapy scores suggested that further refinement of the intervention may be necessary. Results indicate that a larger-scale randomised controlled trial of ACT for TR-GAD is feasible and warranted.
广泛性焦虑障碍(GAD)是老年人中最常见的焦虑障碍。一线治疗包括药物和心理治疗,但许多患者认为这些治疗方法无效或无法接受。对于如何治疗老年难治性广泛性焦虑障碍(TR-GAD)知之甚少。
评估接受和承诺疗法(ACT)治疗老年 TR-GAD 的可接受性、可行性和初步疗效。
从初级和二级保健服务以及社区招募年龄≥65 岁、TR-GAD 患者(定义为对 GAD 治疗无反应、不能耐受或拒绝治疗)。
除了常规治疗外,参与者还接受了最多 16 次一对一的 ACT 治疗,该疗法是专门为老年 TR-GAD 患者开发的。
主要结局是可行性(定义为招募≥32 名参与者,随访时保留≥60%)和可接受性(定义为参与者参加≥10 次治疗,治疗满意度量表得分≥21/30)。次要结局包括焦虑、担忧、抑郁和心理灵活性的测量(在 0 周和 20 周评估)。
共招募了 37 名参与者,30 名(81%)参与者保留,26 名(70%)参与者参加了≥10 次治疗。共有 18/30(60%)名参与者在治疗满意度量表上得分≥21/30。有初步证据表明,ACT 可能改善焦虑、抑郁和心理灵活性。
ACT 治疗 TR-GAD 的可行性和可接受性良好,尽管治疗满意度得分表明干预措施可能需要进一步改进。结果表明,ACT 治疗 TR-GAD 的更大规模随机对照试验是可行且必要的。